Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Number and order of whole cell pertussis vaccines in infancy and disease protection.

Sheridan SL, Ware RS, Grimwood K, Lambert SB.

JAMA. 2012 Aug 1;308(5):454-6. doi: 10.1001/jama.2012.6364. No abstract available. Erratum in: JAMA. 2012 Oct 10;308(14):1432.

PMID:
22851107
[PubMed - indexed for MEDLINE]
2.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
[PubMed - indexed for MEDLINE]
3.

Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

[No authors listed]

MMWR Recomm Rep. 1997 Mar 28;46(RR-7):1-25. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Aug 1;46(30):706.

PMID:
9091780
[PubMed - indexed for MEDLINE]
Free Article
4.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

PMID:
16557217
[PubMed - indexed for MEDLINE]
Free Article
5.

Why do pertussis vaccines fail?

Cherry JD.

Pediatrics. 2012 May;129(5):968-70. doi: 10.1542/peds.2011-2594. Epub 2012 Apr 23. No abstract available.

PMID:
22529282
[PubMed - indexed for MEDLINE]
Free Article
6.

Research aims to boost pertussis control.

Friedrich MJ.

JAMA. 2011 Jul 6;306(1):27-9. doi: 10.1001/jama.2011.888. No abstract available.

PMID:
21730232
[PubMed - indexed for MEDLINE]
7.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
[PubMed - indexed for MEDLINE]
8.

Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.

Reynolds E, Walker B, Xing D, Southern J, Asokanathan C, Dagg B, Corbel M, Miller E.

Vaccine. 2006 Apr 12;24(16):3248-57. Epub 2006 Jan 25.

PMID:
16480794
[PubMed - indexed for MEDLINE]
9.

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.

Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938.

PMID:
20578875
[PubMed - indexed for MEDLINE]
Free Article
10.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
[PubMed - indexed for MEDLINE]
Free Article
11.

[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].

Zawadka M, Lutyńska A.

Przegl Epidemiol. 2012;66(1):99-105. Polish.

PMID:
22708307
[PubMed - indexed for MEDLINE]
Free Article
12.

Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.

McCormack PL.

Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000. Review.

PMID:
22931522
[PubMed - indexed for MEDLINE]
13.

Pertussis vaccine controversies and acellular pertussis vaccine.

Shah RC, Shah AR.

Indian J Pediatr. 2003 Jun;70(6):485-8.

PMID:
12921317
[PubMed - indexed for MEDLINE]
14.

Acellular vaccines and resurgence of pertussis.

Shapiro ED.

JAMA. 2012 Nov 28;308(20):2149-50. doi: 10.1001/jama.2012.65031. No abstract available.

PMID:
23188034
[PubMed - indexed for MEDLINE]
15.

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

Halperin SA, Scheifele D, Barreto L, Pim C, Guasparini R, Medd L, Meekison W, Eastwood BJ.

Pediatr Infect Dis J. 1999 Sep;18(9):772-9.

PMID:
10493336
[PubMed - indexed for MEDLINE]
16.

Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.

Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A.

Dev Biol Stand. 1997;89:315-20.

PMID:
9272365
[PubMed - indexed for MEDLINE]
17.
18.

Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.

Lavigne MV, Castro M, Andino J, Manghi M.

Microbes Infect. 2004 Apr;6(5):481-4.

PMID:
15109963
[PubMed - indexed for MEDLINE]
19.

Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.

Matheson AJ, Goa KL.

Paediatr Drugs. 2000 Mar-Apr;2(2):139-59. Review.

PMID:
10937466
[PubMed - indexed for MEDLINE]
20.

Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.

Tapiainen T, Cherry JD, Heininger U.

Vaccine. 2005 Oct 17;23(43):5106-12.

PMID:
16023771
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk